NASDAQ
Lipella Pharmaceuticals Inc. (LIPO) has a current ratio of 3.47x as of Monday, May 25, 2026. This represents a 38.31% decrease compared to its 12-month average of 5.62x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.